Bipolar I or II Depression and Alcohol Abuse or Dependence Withdrawn Phase 2 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0032831 (Bipolar I or II Depression and Alcohol Abuse or Dependence)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00204503Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or DependenceTreatment